Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
111.38
-0.92 (-0.82%)
At close: May 8, 2026, 4:00 PM EDT
111.26
-0.12 (-0.11%)
After-hours: May 8, 2026, 7:52 PM EDT
Merck & Co. Stock Forecast
Stock Price Forecast
The 17 analysts that cover Merck & Co. stock have a consensus rating of "Buy" and an average price target of $125.29, which forecasts a 12.49% increase in the stock price over the next year. The lowest target is $90 and the highest is $145.
Price Target: $125.29 (+12.49%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Merck & Co. stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 2 | 2 | 3 | 3 |
| Buy | 4 | 4 | 6 | 6 | 7 | 7 |
| Hold | 7 | 7 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 15 | 15 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Initiates $125 | Hold | Initiates | $125 | +12.23% | May 6, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $150 → $145 | Buy | Maintains | $150 → $145 | +30.18% | May 1, 2026 |
| UBS | UBS | Strong Buy Maintains $130 → $145 | Strong Buy | Maintains | $130 → $145 | +30.18% | Apr 13, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $125 → $135 | Buy | Maintains | $125 → $135 | +21.21% | Apr 6, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $142 | Buy | Reiterates | $142 | +27.49% | Mar 30, 2026 |
Financial Forecast
Revenue This Year
67.39B
from 65.01B
Increased by 3.66%
Revenue Next Year
71.06B
from 67.39B
Increased by 5.45%
EPS This Year
5.19
from 7.28
Decreased by -28.73%
EPS Next Year
9.78
from 5.19
Increased by 88.43%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 70.9B | 75.9B | ||||||
| Avg | 67.4B | 71.1B | ||||||
| Low | 64.7B | 66.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 9.0% | 12.6% | ||||||
| Avg | 3.7% | 5.4% | ||||||
| Low | -0.5% | -1.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5.57 | 10.89 | ||||||
| Avg | 5.19 | 9.78 | ||||||
| Low | 4.91 | 8.72 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -23.6% | 110.0% | ||||||
| Avg | -28.7% | 88.4% | ||||||
| Low | -32.6% | 68.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.